Light Ezetimibe Tablet 10 mg (Ezetimibe)

Adult dosage

The recommended dosage for this medicine is 10 mg once a day, taken regardless of meals. When co-administered with HMG-CoA reductase inhibitors, initiate treatment with this medicine at the recommended starting dosage of the HMG-CoA reductase inhibitor, and if the patient is already receiving high doses of HMG-CoA reductase inhibitors, continue administering this medicine while maintaining the dose of the HMG-CoA reductase inhibitor. This medicine

This medicine should not be used in patients with hypersensitivity to its components. Patients with active liver disease or persistent elevated liver enzymes should not take this medicine in conjunction with certain lipid-lowering agents. Pregnant or breastfeeding women should use caution, as co-administration with certain lipid-lowering medications is prohibited. Patients with severely impaired liver function, gallbladder disease, or severe kidney dysfunction should avoid taking this medicine along with certain lipid-lowering agents. Patients with hereditary metabolic disorders like lactose intolerance should also not take this medicine. Patients with severe liver dysfunction may experience increased concentrations of this medicine, leading to unexpected side effects, so it is not recommended. This medicine is generally safe, but side effects such as headache, abdominal pain, diarrhea, fatigue, and muscle pain may occur. In particular, if taken with certain lipid-lowering agents, liver enzyme levels may rise, requiring regular liver function tests. Symptoms like muscle pain or weakness should be reported to a doctor immediately, and in severe cases, drug use should be discontinued. Patients with reduced kidney function can use this medicine, but caution is needed even though no dosage adjustments are required. This medicine can interact with other medications, so it should be discussed with a doctor, especially if the patient is taking cholestyramine, fibrate drugs, anticoagulants, or cyclosporine. Women who are pregnant or may become pregnant should use this medicine cautiously, as it may affect the fetus. Nursing mothers should decide on the use of this medicine based on weighing the risks to the infant against the benefits of the medicine. The use of this medicine is not recommended for children under 6 years of age, but a similar safety profile has been reported for children aged 6 years and older and adolescents. Older adults can also use this medicine, but some patients may respond more sensitively, so caution is needed. There is no specific treatment for overdose, and standard care should be provided based on symptoms. This medicine should be kept out of reach of children, and it is advisable not to store it in a changed container.

Serious side effects

Urticaria, angioedema, elevated levels of liver aminotransferases, hepatitis, liver function abnormalities (risk of jaundice), thrombocytopenia, pancreatitis, renal failure (kidney disease), nephropathy, myopathy, rhabdomyolysis, persistent elevation of aminotransferase levels (more than three times), elevation of serum creatine phosphokinase levels of more than ten times, weakness, muscle pain, kidney damage due to rhabdomyolysis, chest tightness, dyspnea, severe edema, hypertension,

Mild side effects

• Fatigue
• abdominal pain
• diarrhea
• viral infection
• pharyngitis
• sinusitis
• arthralgia
• low back pain
• cough
• chest pain

This medicine is sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to store at room temperature between 1 to 30 degrees Celsius.

Appearance

White to nearly white oblong tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]